The fact that WBR downregulates GSK3β and produces better colon tumor inhibition suggests that other mechanisms are involved in WBR's anti-colon cancer properties and are likely modulated by NF-κB [172, 173]. This evidence concerns the gene GSK3B and colonic neoplasm.